Get the full Laboratoires üma company profile
Access contacts, investors, buying signals & more
Laboratoires üma, a French independent lab focused on women's health and wellness, has raised $4.4M in seed funding. The round drew backing from The Moon Venture, Le DealClub, Kima Ventures and Ring Capital.
The company formulates natural, hormone-free dietary supplements aimed at preserving quality of life during and after menopause, positioning itself as a pioneer in micronutrition and phytotherapy. Its stated mission is to help women live longer and healthier lives.
Vestor Raise : France Seed Spotlight 🌸 Laboratoires üma is making women's midlife health a priority through natural, hormone-free wellness solutions.
French FemTech and HealthTech startup Laboratoires üma is an independent laboratory dedicated to women's health, with a particular focus on perimenopause, menopause, and post-menopause. The company develops naturally derived dietary supplements using micronutrition and phytotherapy to help women manage the physical changes associated with this stage of life. 📍 Location: Lyon, France 🌱 Stage: See
CYTO
CYTO, an Angola-based Fintech company. Quickly aggregate, analyze, and manage your business operations all in one place. Our mission is to accelerate progress towards a more inclusive and resilient Africa by solving Banking Fragmentation challenges for businesses.
$40.0K Angel
today
MB Therapeutics
MB Therapeutics is a pharmaceutical company that offer patient centric solutions to Develop and produce personalized medicines. MB Therapeutics solution is powered by 3D printing, allowing dosage, shape and API customization in GMP environement
$2.2M Seed
3 days ago
Largest funding rounds in Healthcare on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Kismet Australia | Pre-seed | $42.0B | 2y ago |
| 2 |  Johnson & Johnson United States | Unknown | $7.0B |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Nuuri United Kingdom | Seed | $731.3K | today |
| 2 |  Octopath United Kingdom | Seed | $2.0M | today |
Dyameo
Dyameo est une société de recherche & développement dans le domaine des dispositifs médicaux qui conçoit des sondes d'aide au diagnostic de cellules cancéreuses in-vivo. Ce dispositif médical, permet de répondre à la question: "Ces cellules sont-elle cancéreuses?", et cela de manière simple, claire et instantanée. Cette solution de rupture propose de discriminer les cellules cancéreuses à un stade précoce, lors d'examens endoscopiques.
$3.3M Unknown
4 days ago
| 2y ago |
| 3 |  Inari Medical United States | Unknown | $4.9B | 1y ago |
| 4 |  MultiPlan United States | Unknown | $4.5B | 1y ago |
| 5 |  Edwards Lifesciences United States | Unknown | $4.2B | 1y ago |
| 3 |
 Unify Foodworks |
| Seed |
| $525.5K |
| today |
| 4 |  Aerosky Systems Pvt Ltd | Seed | $4.5M | today |
| 5 |  EDJX United States | Seed | $3.0M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
The Moon Venture
VC FIRM
Le DealClub
Unlock 2 more investors and reach their contacts directly.
Start free trial
Bambusa Therapeutics
Recently received
Gallium Defense
Recently received
Hypersonica
Recently received
